Drug
Besufetamig clinical trials
Also written ONO-4685.
- studies test it
- 4
- open now
- 0
- in phase 3
- 0
- first study started
- 2019
How studies write it
Studies that test it under each name
Development codes
- ONO-4685
- 4
Studies by the year they started
4 studies that test it; most in 2019 (1)
| Year | Studies |
|---|---|
| 2019 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 4
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 4 · Other 0
Ono Pharmaceutical Co., Ltd. (2) · Ono Pharmaceutical Co. Ltd (2)
Often tested with
Tested in the same studies.
Related medicines
As reviewed, each with the page that says it.
Studies
Open first, then newest update. How each study uses besufetamig is read from its arms, and is right about nine times in ten.
Testing it · 4
- Study of ONO-4685 in Patients With Relapsed or Refractory T Cell LymphomaActive, not recruitingPhase 1Ono Pharmaceutical Co., Ltd.NCT05079282Written as ONO-4685
- A Phase I Study to Investigate the Tolerability and Safety of ONO-4685 Given as Monotherapy in T Cell Lymphoma and CLL/SLLActive, not recruitingPhase 1Ono Pharmaceutical Co., Ltd.NCT06547528Written as ONO-4685
- Safety, Tolerability, PK, PD and Preliminary Efficacy of ONO-4685CompletedPhase 1Ono Pharmaceutical Co. LtdNCT05332704Written as ONO-4685
- Single Ascending Dose Study to Assess the Safety, Tolerability, PK and PD of ONO-4685 in Japanese and Caucasian Healthy Adult Male SubjectsCompletedPhase 1Ono Pharmaceutical Co. LtdNCT04079062Written as ONO-4685
Codes
What other systems call besufetamig · ClinicalTrials.gg INT015742
- UNII (FDA) 8YCQ8727FBBESUFETAMIGOne source FDA
- NCI Thesaurus C185163BesufetamigOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 8YCQ8727FB | BESUFETAMIG | One source FDA |
| NCI Thesaurus | C185163 | Besufetamig | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.